China Pharma Holdings (CPHI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 756 | 1,026 | 1,136 | 1,134 | 1,100 |
| Cost of Goods | 816 | 1,113 | 1,272 | 1,295 | 1,620 |
| Gross Profit | -60 | -87 | -136 | -161 | -520 |
| Operating Expenses | 1,384 | 678 | 895 | 1,330 | 1,185 |
| Operating Income | -628 | -652 | -759 | -1,196 | -1,085 |
| Interest Expense | 24 | 27 | 28 | 30 | 34 |
| Other Income | 1 | 151 | 1 | 1 | 2 |
| Pre-tax Income | -652 | -528 | -786 | -1,224 | -1,118 |
| Net Income Continuous | -652 | -528 | -786 | -1,224 | -1,118 |
| Net Income | $-652 | $-528 | $-786 | $-1,224 | $-1,118 |
| EPS Basic Total Ops | -0.17 | -0.16 | -0.24 | -0.44 | -0.65 |
| EPS Basic Continuous Ops | -0.17 | -0.16 | -0.24 | -0.46 | -0.65 |
| EPS Diluted Total Ops | -0.17 | -0.16 | -0.24 | -0.44 | -0.65 |
| EPS Diluted Continuous Ops | -0.17 | -0.16 | -0.24 | -0.46 | -0.65 |
| EPS Diluted Before Non-Recurring Items | -0.17 | -0.16 | -0.24 | N/A | -0.60 |
| EBITDA(a) | $-272 | $-331 | $-429 | $-748 | $-388 |